Ionis to present at upcoming investor conferences

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) has announced its management team's upcoming participation in several investor conferences in March 2025. The schedule includes:

• Raymond James 46th Annual Institutional Investors Conference (March 4)
• TD Cowen 45th Annual Health Care Conference (March 4)
• Leerink Partners Global Healthcare Conference (March 11)
• Barclays 27th Annual Global Healthcare Conference (March 12)
• UBS Virtual CNS Day (March 17)
• Stifel Virtual CNS Forum (March 19)

Live webcasts of these presentations will be available on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be accessible within 48 hours and archived for a time.

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

• Raymond James 46^th Annual Institutional Investors Conference on Tuesday, March 4, 2025
• TD Cowen 45^th Annual Health Care Conference on Tuesday, March 4, 2025
• Leerink Partners Global Healthcare Conference 2025 on Tuesday, March 11, 2025
• Barclays 27^th Annual Global Healthcare Conference on Wednesday, March 12, 2025
• UBS Virtual CNS Day 2025 on Monday, March 17, 2025
• Stifel 2025 Virtual CNS Forum on Wednesday, March 19, 2025

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has six marketed medicines and a leading pipeline in neurology, cardiology and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225056433/en/

Ionis Pharmaceuticals Investor Contact:

D. Wade Walke, Ph.D. – ir@ionis.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:

Hayley Soffer – media@ionis.com – 760-603-4679

Source: Ionis Pharmaceuticals, Inc.

FAQ

When is Ionis Pharmaceuticals (IONS) presenting at the Raymond James conference in 2025?

Ionis Pharmaceuticals will present at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025.

How many investor conferences will IONS participate in during March 2025?

IONS will participate in six investor conferences during March 2025, including events hosted by Raymond James, TD Cowen, Leerink Partners, Barclays, UBS, and Stifel.

Where can investors watch the IONS conference presentations in March 2025?

Investors can watch live webcasts of IONS presentations on the company's website at https://ir.ionis.com/events-and-presentations/upcoming-events.

How long will replays of IONS investor conference presentations be available?

Replays of IONS presentations will be available on the company website within 48 hours and will be archived for a time.

Which CNS-focused investor events will IONS participate in during March 2025?

IONS will participate in two CNS-focused events in March 2025: the UBS Virtual CNS Day on March 17 and the Stifel Virtual CNS Forum on March 19.